サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565716

全身麻酔薬の世界市場：タイプ別、投与経路別、手術タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）

General Anesthesia Drugs Market, By Type, By Route Of Administration, By Surgery Type, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
全身麻酔薬の世界市場：タイプ別、投与経路別、手術タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートのハイライト

世界の全身麻酔薬の市場規模は、2023年に51億1,420万米ドルと評価され、2024年～2032年にCAGR4.00%で上昇すると予測されています。

全身麻酔薬市場- 市場力学

低侵襲手術（MIS）で治療される慢性疾患の頻度増加

慢性疾患の有病率の増加が、MIS全身麻酔薬の成長を牽引しています。慢性疾患における外科治療の需要の増加は、手術を希望する患者数の増加に直結するため、安全で効果的な麻酔薬に対する需要の増加に拍車をかけています。回復時間の短縮や入院期間の短縮につながることが多いMIS技術の採用が増加していることも、医療提供者による使用増加の重要な推進力となっています。この動向は、手術中の患者の快適性と安全性を高める高度な全身麻酔薬の開発と採用を促し、効率的な手術ソリューションに対する需要の高まりに対応した市場の拡大に最終的に寄与しています。例えば、Minimal Invasive Surgery Journal（MISジャーナル）に掲載された論文によると、低侵襲手術（MIS）に関する論文が58本受理され、37本の総説、10本の原著論文、1本の系統的レビューが掲載されました。この系統的レビューでは、経カテーテル大動脈弁植え込み術における交連アライメント手術のコンピュータ支援による品質評価が取り上げられており、肝細胞がんにおける冠動脈再アクセスや経カテーテル大動脈弁植え込み術（TAVI）のやり直しを容易にする新たなフロンティアとなる可能性があります。

全身麻酔薬市場-主要洞察

当社のリサーチアナリストは、世界市場は2024年～2032年にCAGR4.00%で発展すると予測しています。

2023年には、タイプ別では、プロポフォールセグメントの市場シェアが最も高くなりました。

投与経路別では、静脈内投与（IV）セグメントが2023年の市場を独占しました。

手術タイプ別では、膝関節・股関節置換術のセグメントが予測期間中に市場をリードするとみられます。

地域別では、2023年に北米が最も高い収益を上げました。

全身麻酔薬市場-セグメンテーション分析：

世界の全身麻酔薬市場は、タイプ、投与経路、手術タイプ、エンドユーザー、地域の5つのカテゴリーに分類されます。

市場はタイプ別に4つのセグメントに分類され、プロポフォール、デスフルラン、セボフルラン、その他です。2023年には、プロポフォールカテゴリが市場を独占し、予測期間中に最も速いCAGRで成長すると予測されています。プロポフォールは、患者の快適性と手術効率を向上させる、迅速な麻酔開始と回復時間で知られています。麻酔の導入と維持に頻繁に使用され、幅広い外科手術や診断手術に適応可能な選択肢となっています。また、半減期が短く代謝が速いなど、薬物動態プロファイルが優れていることも、麻酔科医にとって魅力となっています。

市場は、投与経路別に吸入と静脈内の2種類に分けられます。最も売上シェアが高いのは静脈内投与（IV）分野です。この成長動向は、主に静脈内麻酔薬投与の進歩、有効性、利便性など、多くの重要な変数によってもたらされています。静脈麻酔が支持されているのは、効果の発現が早く、薬剤投与を正確にコントロールできるためであり、これらは複雑な外科手術に対応し、患者の安全を保証するために不可欠です。投与量をリアルタイムで変更できるため、麻酔科医は患者の要望や手術要件に基づいて麻酔深度を調整することができます。

全身麻酔薬市場-地理的洞察

地理的には、北米、アジア太平洋、中東・アフリカ、ラテンアメリカ、欧州が含まれます。これらのゾーンは、どの国がビジネスをもたらすかによってさらに分けられます。

北米の全身麻酔薬市場は、慢性疾患の有病率の高さ、技術的な改善、重要な医療インフラなど、多くの重要な変数によって牽引され、2023年に支配的となりました。CVDやがんなど、外科的処置が頻繁に必要となる慢性疾患の頻度が増加しているため、全身麻酔の需要が高まっています。

アジア太平洋の全身麻酔薬市場は、医療コストの上昇、外科手術の必要性が高まる人口増加、技術向上の結果、急速に拡大しています。アジア太平洋の人口が多く多様であること、慢性疾患の頻度が増加していること、外科手術の必要性が高まっていることなどが、全身麻酔の必要性を高めています。中国とインドの政府は、医療・インフラと医療技術に多額の投資を行っており、これが市場成長の原動力となっています。

全身麻酔薬市場-競合情勢：

全身麻酔薬市場は、ファイザー、パイオンAG、B.Braun Melsungen、Avet Pharmaceuticals Inc.などの老舗製薬会社が、豊富な製品ラインアップとスムーズな流通チャネルで市場を独占しています。これらの企業は研究開発への投資も増やしています。また、中小企業やジェネリック医薬品メーカーが市場シェアを追求する中で、低価格版の存在感も増しています。安全で効果的な麻酔薬への需要がますます高まる中、各社が製品ラインナップの充実を図り、市場を拡大するために、戦略的提携、合併、買収が盛んに行われています。

目次

第1章 全身麻酔薬市場の概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 全身麻酔薬の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 全身麻酔薬産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 全身麻酔薬市場：COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 全身麻酔薬市場の情勢

  • 全身麻酔薬市場シェア分析：2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 全身麻酔薬市場- タイプ別

  • 概要
    • タイプ別のセグメントシェア分析
    • プロポフォール
    • デスフルラン
    • セボフルラン
    • その他

第8章 全身麻酔薬市場- 投与経路別

  • 概要
    • 投与経路別のセグメントシェア分析
    • 吸入
    • 静脈内

第9章 全身麻酔薬市場- 手術タイプ別

  • 概要
    • 手術タイプ別のセグメントシェア分析
    • 膝関節・股関節置換術
    • がん手術
    • 心臓手術
    • 一般外科

第10章 全身麻酔薬市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 外来手術センター
    • 病院

第11章 全身麻酔薬市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 全身麻酔薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer Inc.
    • Paion AG
    • B. Braun Melsungen
    • Avet Pharmaceuticals Inc
    • Baxter International Inc.
    • Abbott Laboratories
    • Fresenius SE and Co. KGaA
    • Abbvie Inc,
    • AstraZeneca plc
    • Hikma Pharmaceuticals plc
    • その他

第13章 アナリストの全方位展望

目次
Product Code: ANV3920

REPORT HIGHLIGHT

General Anesthesia Drugs market size was evaluated at USD 5,114.2 million in 2023, rising at a CAGR of 4.00% from 2024 to 2032.

General anesthetic drugs are essential for establishing and maintaining a state of unconsciousness without pain during a variety of surgical operations. These medications, which are delivered intravenously or via inhalation, are utilized in a variety of surgeries, including cardiac, orthopedic, oncology, and gastrointestinal procedures.

General Anesthesia Drugs Market- Market Dynamics

Increasing Frequency of Chronic Illnesses Treated with Minimally Invasive Surgery (MIS)

Higher prevalence rates of chronic diseases are driving the growth of MIS general anesthesia drugs. A greater demand for surgical treatment in chronic diseases translates directly into a higher number of patients seeking surgery, thus fueling increased demand for safe and effective anesthesia drugs. Increased adoption of MIS techniques, which often result in quicker recovery times and shorter hospital stays, are an important driver of increased use by healthcare providers. This trend encourages the development and adoption of advanced general anesthesia drugs that enhance patient comfort and safety during procedures, ultimately contributing to the expansion of the market in response to the growing demand for efficient surgical solutions. For instance, an article published in the Minimal Invasive Surgery Journal (MIS journal) stated that 58 papers on minimal invasive surgery (MIS) were accepted and published, including 37 reviews, 10 original articles, and one systematic review. The systematic study addressed computer-assisted quality evaluation for surgeries commissural alignment in transcatheter aortic valve implantation, which may be a new frontier to ease coronary re-access and redo transcatheter aortic valve implantation (TAVI) in hepatocellular carcinoma.

General Anesthesia Drugs Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of 4.00% from 2024 to 2032.

In 2023, the propofol sector had the highest market share based on Type segmentation.

Based on Route Of Administration segmentation, The intravenous (IV) Route Of Administration segment dominated the market in 2023.

The knee and hip replacement sector is expected to lead the market over the projection period, according to Surgery Type segmentation.

On the basis of region, in 2023, North America generated the highest revenue.

General Anesthesia Drugs Market- Segmentation Analysis:

The global vehicle-mounted spotlights market is divided into five categories: Type, Route Of Administration, Surgery Type, End-user, and region.

The market is classified into four segments based on the type: Propofol, Desflurane, Sevoflurane, and Others. In 2023, the propofol category dominated the market and is predicted to grow at the quickest CAGR over the forecast period. Propofol is known for its rapid onset and recovery times, which improve patient comfort and procedural efficiency. It is frequently used for anesthesia induction and maintenance, giving it an adaptable option for a wide range of surgical and diagnostic operations. The agent's good pharmacokinetic profile, which includes a short half-life and quick metabolism, adds to its appeal among anesthesiologists.

The market is separated into two types based on the route of administration: inhalation and intravenous. The intravenous (IV) sector had the highest revenue share. This growing trend is primarily driven by a number of significant variables, including advances in IV anesthetic delivery, efficacy, and convenience. IV anesthesia is favored because of its quick onset of effect and precise control over drug administration, which are critical for handling complex surgical operations and guaranteeing patient safety. The ability to modify dosage in real time enables anesthesiologists to tailor anesthetic depth based on the patient's demands and the surgical requirements.

General Anesthesia Drugs Market- Geographical Insights

Geographically, this market encompasses North America, Asia Pacific, the Middle East, and Africa, Latin America, Europe. These zones are further split based on which countries bring business.

The North American general anesthesia medicines market dominated in 2023, driven by a number of crucial variables, such as the high prevalence of chronic diseases, technological improvements, and significant healthcare infrastructure. The increased frequency of chronic illnesses such as CVD and cancer, which frequently necessitate surgical procedures, increases the demand for general anesthesia.

The Asia Pacific general anesthetic medicines market is quickly expanding as a result of rising healthcare costs, a growing population with increased surgical needs, and technological improvements. The large and diverse population of APAC, as well as the rising frequency of chronic illnesses and the requirement for surgical operations, all contribute to increased need for general anesthesia. Governments in China and India are investing heavily in healthcare infrastructure and medical technology, which is driving market growth.

General Anesthesia Drugs Market- Competitive Landscape:

The general anesthesia drugs market is characterized by a few main players, including established pharmaceutical companies such as Pfizer Inc., Paion AG, B. Braun Melsungen, and Avet Pharmaceuticals Inc., which dominate the market with a massive product line and smooth distribution channels. These players have also increased their investments in R&D. Low-cost versions are also gaining prominence in the quest for market share by smaller firms and generic manufacturers. Strategic alliances, mergers, and acquisitions mushroom as companies strive to build strength in their product offerings and increase their reach into the marketplace at a time when demand for safe, effective anesthesia is ever-increasing.

Recent Developments:

In April 2024, Baxter increased their pharmaceutical offering in the United States with the introduction of Ropivacaine Hydrochloride Injection, USP. This new medicine is packaged in a convenient, ready-to-use, single-dose infusion bag.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERAL ANESTHESIA DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Paion AG
  • B. Braun Melsungen
  • Avet Pharmaceuticals Inc
  • Baxter International Inc.
  • Abbott Laboratories
  • Fresenius SE and Co. KGaA
  • Abbvie Inc,
  • AstraZeneca plc
  • Hikma Pharmaceuticals plc
  • Others

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Propofol
  • Desflurane
  • Sevoflurane
  • Others

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Inhalation
  • Intravenous

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY SURGERY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Knee and hip replacements
  • Cancer surgery
  • Heart surgeries
  • General surgery

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Ambulatory surgical centers
  • Hospital

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. General Anesthesia Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. General Anesthesia Drugs Market Snippet by Type
    • 2.1.2. General Anesthesia Drugs Market Snippet by Route Of Administration
    • 2.1.3. General Anesthesia Drugs Market Snippet by Surgery Type
    • 2.1.4. General Anesthesia Drugs Market Snippet by End-user
    • 2.1.5. General Anesthesia Drugs Market Snippet by Country
    • 2.1.6. General Anesthesia Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. General Anesthesia Drugs Key Market Trends

  • 3.1. General Anesthesia Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. General Anesthesia Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. General Anesthesia Drugs Market Opportunities
  • 3.4. General Anesthesia Drugs Market Future Trends

4. General Anesthesia Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. General Anesthesia Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. General Anesthesia Drugs Market Landscape

  • 6.1. General Anesthesia Drugs Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. General Anesthesia Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Propofol
    • 7.1.3. Desflurane
    • 7.1.4. Sevoflurane
    • 7.1.5. Others

8. General Anesthesia Drugs Market - By Route Of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route Of Administration, 2023 & 2032 (%)
    • 8.1.2. Inhalation
    • 8.1.3. Intravenous

9. General Anesthesia Drugs Market - By Surgery Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Surgery Type, 2023 & 2032 (%)
    • 9.1.2. Knee and hip replacements
    • 9.1.3. Cancer surgery
    • 9.1.4. Heart surgeries
    • 9.1.5. General surgery

10. General Anesthesia Drugs Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
    • 10.1.2. Ambulatory surgical centers
    • 10.1.3. Hospital

11. General Anesthesia Drugs Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. General Anesthesia Drugs Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. General Anesthesia Drugs Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. General Anesthesia Drugs Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. General Anesthesia Drugs Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. General Anesthesia Drugs Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- General Anesthesia Drugs Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc.
    • 12.2.2. Paion AG
    • 12.2.3. B. Braun Melsungen
    • 12.2.4. Avet Pharmaceuticals Inc
    • 12.2.5. Baxter International Inc.
    • 12.2.6. Abbott Laboratories
    • 12.2.7. Fresenius SE and Co. KGaA
    • 12.2.8. Abbvie Inc,
    • 12.2.9. AstraZeneca plc
    • 12.2.10. Hikma Pharmaceuticals plc
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us